COPD (Chronic Obstructive Pulmonary Disease) Clinical Trial
Official title:
RETHINC: REdefining THerapy In Early COPD for the Pulmonary Trials Cooperative
The study hypothesis is that symptomatic current and former smokers with spirometric values within the normal range (post-bronchodilator FEV1/FVC≥0.70 and post-BD FVC ≥ 70% predicted will still derive symptomatic benefit from long-acting bronchodilator therapy even though they are excluded from current GOLD guideline recommendations.
RETHINC is a 12-week multicenter, randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy and safety of indacaterol/glycopyrrolate 27.5/15.6 mcg inhaled twice daily in symptomatic current and former smokers with respiratory symptoms despite preserved spirometry as defined by CAT ≥ 10 and post-bronchodilator FEV1/FVC ratio ≥0.70, respectively. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05553847 -
Automated Oxygen Titration in Daily Life in Patients With COPD on Home Oxygen
|
N/A | |
| Completed |
NCT02859194 -
The Effect of Lt to Rt Shunt Using Veno-veno-arterial Extracorporeal Membrane Oxygenation (ECMO) on Coronary Oxygenation in Lung Transplantation Patients
|
N/A | |
| Not yet recruiting |
NCT03921983 -
Non Invasive Evaluation of Muscle Hypoxia in COPD Patient (EVANIMUS)
|
N/A | |
| Recruiting |
NCT05572632 -
Rehabilitation in Safety-net Environments (RISE) to Improve Outcomes in Vulnerable Patients With COPD
|
N/A | |
| Recruiting |
NCT06075095 -
A Study to Investigate the Effect on Lung Function of an Approved COPD Treatment (BGF, With HFA Propellant) Compared to BGF Formulated With a New Propellant (HFO) in Participants 40 to 80 Years of Age With COPD
|
Phase 3 | |
| Recruiting |
NCT06283966 -
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
|
Phase 3 | |
| Not yet recruiting |
NCT06158633 -
A Pilot Observation and Feasibility Study of Prevora, Integrated Into Homecare Visits of High-risk Adults
|
||
| Recruiting |
NCT05811832 -
Evaluation in Elderly Individuals With Chronic Obstructive Pulmonary Disease(COPD)
|
||
| Completed |
NCT03197818 -
Active Controlled Trial of CHF5993 Pressurized Metered-dose Inhaler ( pMDI) vs Symbicort®Turbuhaler® in Patients With Chronic Obstructive Pulmonary Disease ( COPD)
|
Phase 3 |